AstraZeneca PLC Files 6-K Report
Ticker: AZN · Form: 6-K · Filed: Aug 28, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Aug 28, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, sec-filing, routine-report
Related Tickers: AZN
TL;DR
AZN filed a 6-K, standard foreign issuer report. Nothing new.
AI Summary
AstraZeneca PLC filed a Form 6-K on August 28, 2025, reporting its status as a foreign issuer. The company, formerly known as ZENECA GROUP PLC until April 22, 1993, is based in Cambridge, United Kingdom, and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing confirms AstraZeneca's ongoing reporting obligations as a foreign issuer with the SEC, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not contain new material financial or operational information.
Key Numbers
- 001-11960 — SEC File Number (Identifies the specific filing with the SEC)
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the report
- ZENECA GROUP PLC (company) — Former name of AstraZeneca PLC
- 19930422 (date) — Date of name change from ZENECA GROUP PLC
- 20250828 (date) — Filing date and period of report
- 001-11960 (dollar_amount) — SEC file number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to furnish information which the registrant may be required to make public pursuant to the laws of the registrant's home country or which it may publish, file or make public pursuant to the laws of any stock exchange on which its securities are traded.
When was AstraZeneca PLC formerly known as ZENECA GROUP PLC?
AstraZeneca PLC was formerly known as ZENECA GROUP PLC as of April 22, 1993.
What is AstraZeneca PLC's primary industry classification?
AstraZeneca PLC's standard industrial classification is Pharmaceutical Preparations [2834].
Where is AstraZeneca PLC's principal executive office located?
AstraZeneca PLC's principal executive office is located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Does AstraZeneca PLC file annual reports under Form 20-F or Form 40-F?
AstraZeneca PLC indicates it files annual reports under cover of Form 20-F.
Filing Stats: 469 words · 2 min read · ~2 pages · Grade level 14.6 · Accepted 2025-08-28 11:14:38
Filing Documents
- a0720x.htm (6-K) — 16KB
- 0001654954-25-010131.txt ( ) — 17KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 28 August 2025     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary